# Intravenous Fosfomycin Pharmacokinetics Study

> **NCT03910673** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 39 (actual)

## Conditions studied

- Bacterial Infection
- Multiple-drug Resistance
- Pathogen Resistance

## Interventions

- **DRUG:** Fosfomycin disodium

## Key facts

- **NCT ID:** NCT03910673
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-27
- **Primary completion:** 2020-12-17
- **Final completion:** 2020-12-17
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03910673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03910673, "Intravenous Fosfomycin Pharmacokinetics Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03910673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*